文献速递肿瘤 PET/CT神经核医学

完全缓解30年后复发:肾细胞癌转移在18F-FDG与68Ga-DOTATATE PET/CT上模仿胰腺神经内分泌肿瘤

After 30 Years of Remission, Recurrence With Renal Cell Carcinoma Metastasis Mimicking Pancreatic Neuroendocrine Tumor on 18 F-FDG and 68 Ga-DOTATATE PET/CT.
PubMed 文献 · Clin Nucl Med · 2024-11-27

一名75岁男性,既往因透明细胞肾细胞癌行左肾切除术且处于缓解期,因评估胰腺体部病变行68Ga-DOTATATE PET/CT,显示胰腺体部肿块伴68Ga-DOTATATE摄取强烈。患者不愿手术,随访中因肿块增大行18F-FDG PET/CT,显示胰腺体部病变FDG摄取轻度,组织病理学检查证实为肾细胞癌转移。

要点

  • 肾细胞癌转移可在68Ga-DOTATATE PET/CT上表现为摄取强烈,模仿胰腺神经内分泌肿瘤。
  • 同一胰腺转移灶在18F-FDG PET/CT上仅见FDG摄取轻度。
  • 组织病理学检查证实胰腺体部病变为肾细胞癌转移。

核心结论

  • 肾细胞癌转移可在68Ga-DOTATATE PET/CT上模仿胰腺神经内分泌肿瘤,最终经组织病理学检查证实为肾细胞癌转移。

研究设计与样本

  • 本文为病例报告,报告一名75岁男性透明细胞肾细胞癌左肾切除后缓解期患者。

主要发现

  • 68Ga-DOTATATE PET/CT显示胰腺体部肿块伴68Ga-DOTATATE摄取强烈。
  • 随访中因肿块增大行18F-FDG PET/CT,显示胰腺体部病变FDG摄取轻度。
  • 组织病理学检查证实胰腺体部病变为肾细胞癌转移。

临床怎么用

  • 患者因胰腺体部病变行68Ga-DOTATATE PET/CT评估,因不愿手术而随访。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 75-year-old man with a previous history of left nephrectomy for clear cell renal cell carcinoma in remission was underwent 68 Ga-DOTATATE PET/CT imaging for evaluation of pancreatic body lesion. It showed a mass with intense 68 Ga-DOTATATE uptake in the pancreatic corpus. During the follow-up of the patient who did not want to undergo surgery, 18 F-FDG PET/CT scan was performed due to the increase in the size of the mass, and mild FDG uptake was detected in the pancreatic corpus lesion, and histopathological examination was confirmed as renal cell carcinoma metastasis.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Aydinbelge Dizdar N, Erdem Karaoglu A, Ozmen O, et al. After 30 Years of Remission, Recurrence With Renal Cell Carcinoma Metastasis Mimicking Pancreatic Neuroendocrine Tumor on 18 F-FDG and 68 Ga-DOTATATE PET/CT. Clin Nucl Med. 2024. PMID: 39480230. doi:10.1097/RLU.0000000000005550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。